Erythromycin Enhances CD4^+Foxp3^+ Regulatory T-Cell Responses in a Rat Model of Smoke-Induced Lung Inflammation

Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythrom...

Full description

Saved in:
Bibliographic Details
Published inMediators of Inflammation Vol. 2012; no. 2012; pp. 725 - 733
Main Authors Deng, Jing-Min, Li, Mei-Hua, Zhang, Jian-Quan, He, Zhi-Yi, Huang, Qiu-Ping, Zhong, Xiao-Ning, Qiu, Shi-Lin, Bai, Jing, Liu, Guang-Nan
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Limiteds 01.01.2012
Hindawi Publishing Corporation
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.
AbstractList Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.
Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4 + Foxp3 + Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.
Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF- α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF- α in the BALF and lung damages but increased the numbers of CD4 + Foxp3 + Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.
Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is no information on whether erythromycin can modulate regulatory T-cell (Treg) response. This study is aimed at examining the impact of erythromycin on Treg response in the lungs in a rat model of smoking-induced emphysema. Male Wistar rats were exposed to normal air or cigarette smoking daily for 12 weeks and treated by gavage with 100 mg/kg of erythromycin or saline daily beginning at the forth week for nine weeks. The lung inflammation and the numbers of inflammatory infiltrates in bronchoalveolar lavage fluid (BALF) were characterized. The frequency, the number of Tregs, and the levels of Foxp3 expression in the lungs and IL-8, IL-35, and TNF-α in BALF were determined by flow cytometry, RT-PCR and ELISA, respectively. Treatment with erythromycin reduced smoking-induced inflammatory infiltrates, the levels of IL-8 and TNF-α in the BALF and lung damages but increased the numbers of CD4+Foxp3+ Tregs and the levels of Foxp3 transcription in the lungs, accompanied by increased levels of IL-35 in the BALF of rats. Our novel data indicated that erythromycin enhanced Treg responses, associated with the inhibition of smoking-induced inflammation in the lungs of rats.
Author Huang, Qiu-Ping
Qiu, Shi-Lin
He, Zhi-Yi
Li, Mei-Hua
Bai, Jing
Deng, Jing-Min
Liu, Guang-Nan
Zhong, Xiao-Ning
Zhang, Jian-Quan
AuthorAffiliation Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China
AuthorAffiliation_xml – name: Department of Respiratory Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China
Author_xml – sequence: 1
  fullname: Deng, Jing-Min
– sequence: 2
  fullname: Li, Mei-Hua
– sequence: 3
  fullname: Zhang, Jian-Quan
– sequence: 4
  fullname: He, Zhi-Yi
– sequence: 5
  fullname: Huang, Qiu-Ping
– sequence: 6
  fullname: Zhong, Xiao-Ning
– sequence: 7
  fullname: Qiu, Shi-Lin
– sequence: 8
  fullname: Bai, Jing
– sequence: 9
  fullname: Liu, Guang-Nan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22701274$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9v0zAQgCM0xLrBE8-gPCKqMP-KnbxMQqWDSkWgMV5nXRy7dUns4iRA_3vcZpsoQuLpZN9330l3d5acOO90kjzH6A3GeX5BECYXDCNCyaNkghnnGS44PkkmqOQkK2mOT5OzrtsghHLGiifJKSEiFgk2SbbzsOvXwbc7ZV06d2twSnfp7B27nV75X1t6O02v9WpooPdhl95kM9008afbetdFMBZBeg19-tHXukm9Sb-0_pvOFq4elK7T5eBW6cKZBtoWeuvd0-SxgabTz-7iefL1an4z-5AtP71fzN4uM8gp7zNhQFfU5IrrQrOSK6WIqnEBAoAZTglh3CCBWCHyoqoA0yrXBedIM0VVaeh5shi9tYeN3AbbQthJD1YePnxYSQi9VY2WTICJ1UIwYAzAAK5MoQWPekR1XUfX5ejaDlWra6VdH6A5kh5nnF3Llf8hKRWY5nkUvLoTBP990F0vW9upOElw2g-djMtDBSlG9OWfvR6a3K8sAngEVPBdF7SRyvaH0cbWtokuuT8LuT8LOZ5FrJn-VXOv_Tf9eqTX1tXw0_4HfjHCOiLawANclkWJ9vnlmAcbbG_lxg_BxcXLz9HCUU72Qz4YozMGgSjCCGF2_BAkl4JS-huraeJx
CitedBy_id crossref_primary_10_1152_ajplung_00180_2022
crossref_primary_10_1080_15412555_2016_1192112
crossref_primary_10_1016_j_molimm_2021_01_009
crossref_primary_10_1155_2020_1387952
crossref_primary_10_5582_ddt_2018_01008
crossref_primary_10_1097_CM9_0000000000000248
crossref_primary_10_1007_s10266_023_00843_8
crossref_primary_10_3109_02770903_2015_1038390
crossref_primary_10_1016_j_intimp_2022_108938
crossref_primary_10_1152_ajplung_00292_2014
crossref_primary_10_1111_1751_2980_12218
crossref_primary_10_1177_1753465816682677
crossref_primary_10_3389_fimmu_2018_01545
crossref_primary_10_1002_mrm_26566
crossref_primary_10_1089_jir_2012_0086
crossref_primary_10_1186_s13054_024_05006_x
crossref_primary_10_1016_j_jneuroim_2019_05_005
crossref_primary_10_3389_fphar_2014_00233
crossref_primary_10_1016_j_cca_2016_09_005
crossref_primary_10_1111_imm_13820
crossref_primary_10_1016_j_rmed_2016_06_021
crossref_primary_10_1016_j_bbrc_2015_07_133
crossref_primary_10_1016_j_healun_2015_10_041
crossref_primary_10_1038_s41419_019_1909_2
Cites_doi 10.1136/thx.2006.071068
10.1164/rccm.200806-905OC
10.1111/j.1365-2249.2005.02754.x
10.1378/chest.125.2_suppl.70S
10.1146/annurev.immunol.18.1.423
10.1038/nm1583
10.2165/00003495-200767070-00002
10.1007/BF03256601
10.1183/09031936.00000209
10.1179/joc.2008.20.5.604
10.1164/ajrccm.165.8.2103094
10.1164/rccm.200703-456SO
10.1056/NEJMra055446
10.1371/journal.pmed.0010008
10.1111/j.1365-2567.2005.02317.x
10.1136/thorax.58.10.832
10.1164/rccm.200707-1134OC
10.1038/ni1180
10.1164/rccm.200801-145OC
10.1038/nature06306
10.1038/nm1343
10.1159/000195915
10.1080/15287398509530760
10.1038/cmi.2009.11
10.1016/j.ijporl.2006.10.016
10.1164/ajrccm.163.5.2101039
10.1002/jcb.22430
10.1152/ajplung.00093.2005
10.1136/thx.2006.072348
10.1016/j.jdermsci.2009.01.007
10.1111/j.1440-1843.2006.00845.x
10.1164/rccm.2107139
10.1016/j.coi.2005.09.002
10.4049/jimmunol.175.12.8069
ContentType Journal Article
Copyright Copyright © 2012 Jing Bai et al.
Copyright © 2012 Jing Bai et al. 2012
Copyright_xml – notice: Copyright © 2012 Jing Bai et al.
– notice: Copyright © 2012 Jing Bai et al. 2012
DBID 188
ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1155/2012/410232
DatabaseName Chinese Electronic Periodical Services (CEPS)
الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1466-1861
Editor Asano, Kazuhito
Editor_xml – sequence: 1
  givenname: Kazuhito
  surname: Asano
  fullname: Asano, Kazuhito
EndPage 733
ExternalDocumentID oai_doaj_org_article_47afb5e774a44aafa1bf8e7607003edd
PMC3371355
22701274
10_1155_2012_410232
998902
P20160527003_201212_201703010014_201703010014_725_733
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
188
24P
29M
2UF
2WC
36B
4.4
53G
5GY
5VS
AAFWJ
AAJEY
ABDBF
ACGFO
ACIHN
ADBBV
ADRAZ
AEAQA
AENEX
AFPKN
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BCNDV
CEFSP
CNMHZ
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
GX1
HYE
IAO
IGS
IHR
IL9
INH
INR
ITC
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RHU
RHX
RNS
RPM
SV3
TR2
TUS
UZ5
WOQ
WOW
~8M
3V.
7X7
88E
8FE
8FH
8FI
8FJ
8G5
ABUWG
ADJCN
AFKRA
AHFXO
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
DWQXO
FYUFA
GNUQQ
GUQSH
H13
HCIFZ
HMCUK
IPNFZ
LK8
M1P
M2O
M7P
OVD
PIMPY
PQQKQ
PROAC
PSQYO
RIG
TEORI
UKHRP
RHW
0R~
AAYXX
ACCMX
ACUHS
CITATION
OVT
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7X8
5PM
ID FETCH-LOGICAL-a536t-7faeb3f5c6e8e496ccc2cd18a7aa4f632246f07048758bba13b5e8660e4c3c9f3
IEDL.DBID M48
ISSN 0962-9351
1466-1861
IngestDate Wed Aug 27 01:27:46 EDT 2025
Thu Aug 21 18:06:31 EDT 2025
Fri Jul 11 05:25:50 EDT 2025
Mon Jul 21 05:50:12 EDT 2025
Tue Jul 01 03:54:30 EDT 2025
Thu Apr 24 22:53:41 EDT 2025
Sun Jun 02 18:48:58 EDT 2024
Tue Nov 26 17:08:50 EST 2024
Tue Oct 01 22:52:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2012
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a536t-7faeb3f5c6e8e496ccc2cd18a7aa4f632246f07048758bba13b5e8660e4c3c9f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Kazuhito Asano
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2012/410232
PMID 22701274
PQID 1020828355
PQPubID 23479
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_47afb5e774a44aafa1bf8e7607003edd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3371355
proquest_miscellaneous_1020828355
pubmed_primary_22701274
crossref_citationtrail_10_1155_2012_410232
crossref_primary_10_1155_2012_410232
hindawi_primary_10_1155_2012_410232
emarefa_primary_998902
airiti_journals_P20160527003_201212_201703010014_201703010014_725_733
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
PublicationTitle Mediators of Inflammation
PublicationTitleAlternate Mediators Inflamm
PublicationYear 2012
Publisher Hindawi Limiteds
Hindawi Publishing Corporation
Wiley
Publisher_xml – name: Hindawi Limiteds
– name: Hindawi Publishing Corporation
– name: Wiley
References (33) 2009; 179
(12) 2005; 17
(9) 2005; 6
(23) 2002; 1
(25) 2007; 67
(13) 2006; 354
(29) 1985; 16
(3) 2003; 58
(20) 2006; 290
(30) 1967; 95
(7) 2000; 18
(16) 2007; 62
(31) 2008; 178
(15) 2007; 13
(27) 2009; 33
(5) 2004; 1, article e8
(2) 2007; 176
(32) 2004; 125
(10) 2007; 450
(14) 2005; 140
(19) 2010; 109
(26) 2008; 177
(6) 1999; 160
(22) 1991; 58
(35) 2007; 71
(28) 2003; 26
(36) 2009; 54
(17) 2007; 62
(4) 2002; 165
(24) 2006; 11
(11) 2006; 12
(21) 2002; 165
(34) 2009; 6
(8) 2006; 117
(1) 2001; 163
(18) 2008; 20
(37) 2005; 175
24
25
26
27
(33) 2004; 125
(38) 2005; 175
10
32
11
12
34
13
35
14
36
15
37
16
17
19
2
3
4
5
8
9
20
16085674 - Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L75-85
18033300 - Nature. 2007 Nov 22;450(7169):566-9
11316667 - Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
4087316 - J Toxicol Environ Health. 1985;16(3-4):523-34
19950196 - J Cell Biochem. 2010 Feb 15;109(3):532-41
19407062 - Eur Respir J. 2009 May;33(5):1239
16540617 - N Engl J Med. 2006 Mar 16;354(11):1166-76
14514931 - Thorax. 2003 Oct;58(10):832-4
15526056 - PLoS Med. 2004 Oct;1(1):e8
1745845 - Respiration. 1991;58(3-4):145-9
14720429 - Zhonghua Jie He He Hu Xi Za Zhi. 2003 Dec;26(12):750-5
16476048 - Immunology. 2006 Mar;117(3):289-300
19060231 - Am J Respir Crit Care Med. 2009 Feb 15;179(4):271-8
17137638 - Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):297-305
6023510 - Am Rev Respir Dis. 1967 May;95(5):765-73
19403056 - Cell Mol Immunol. 2009 Apr;6(2):81-6
10556164 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S21-5
17450149 - Nat Med. 2007 May;13(5):567-9
11956054 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1113-8
15807863 - Clin Exp Immunol. 2005 May;140(2):360-7
16635082 - Respirology. 2006 May;11(3):249-61
18723437 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47
12016104 - Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9
16209918 - Curr Opin Immunol. 2005 Dec;17(6):638-42
17507545 - Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
14720066 - Am J Respir Med. 2002;1(2):119-31
19251402 - J Dermatol Sci. 2009 Jun;54(3):185-91
19028624 - J Chemother. 2008 Oct;20(5):604-8
17311843 - Thorax. 2007 May;62(5):411-5
10837065 - Annu Rev Immunol. 2000;18:423-49
17557771 - Thorax. 2007 Nov;62(11):938-43
16462800 - Nat Med. 2006 Feb;12(2):178-80
17947611 - Am J Respir Crit Care Med. 2008 Jan 15;177(2):148-55
14872003 - Chest. 2004 Feb;125(2 Suppl):70S-78S
15785759 - Nat Immunol. 2005 Apr;6(4):338-44
16339544 - J Immunol. 2005 Dec 15;175(12):8069-76
17488142 - Drugs. 2007;67(7):965-74
References_xml – volume: 176
  start-page: 532
  issue: 6
  year: 2007
  end-page: 555
  ident: 2
  article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
– volume: 18
  start-page: 423
  year: 2000
  end-page: 449
  ident: 7
  article-title: Regulatory T cells in autoimmmunity
– volume: 20
  start-page: 604
  issue: 5
  year: 2008
  end-page: 608
  ident: 18
  article-title: Effect of long-term and low-dose administration of erythromycin on proliferation of T lymphocytes stimulated with mitogens
– volume: 26
  start-page: 750
  issue: 12
  year: 2003
  end-page: 755
  ident: 28
  article-title: An experimental study on airway inflammation and remodeling in a rat model of chronic bronchitis and emphysema
– volume: 62
  start-page: 411
  issue: 5
  year: 2007
  end-page: 415
  ident: 16
  article-title: Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
– volume: 177
  start-page: 148
  issue: 2
  year: 2008
  end-page: 155
  ident: 26
  article-title: Clarithromycin targets neutrophilic airway inflammation in refractory asthma
– volume: 109
  start-page: 532
  issue: 3
  year: 2010
  end-page: 541
  ident: 19
  article-title: Anti-inflammatory function of withangulatin a by targeted inhibiting COX-2 expression via MAPK and NF- B pathways
– volume: 6
  start-page: 81
  issue: 2
  year: 2009
  end-page: 86
  ident: 34
  article-title: Chronic obstructive pulmonary disease: evidence for an autoimmune component
– volume: 54
  start-page: 185
  issue: 3
  year: 2009
  end-page: 191
  ident: 36
  article-title: Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells
– volume: 11
  start-page: 249
  issue: 3
  year: 2006
  end-page: 261
  ident: 24
  article-title: Diffuse panbronchiolitis in East Asia
– volume: 58
  start-page: 145
  issue: 3-4
  year: 1991
  end-page: 149
  ident: 22
  article-title: Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis
– volume: 33
  issue: 5, article 1239
  year: 2009
  ident: 27
  article-title: Macrolide therapy in asthma: limited treatment, long-term improvement
– volume: 165
  start-page: 1404
  issue: 10
  year: 2002
  end-page: 1409
  ident: 4
  article-title: Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease
– volume: 179
  start-page: 271
  issue: 4
  year: 2009
  end-page: 278
  ident: 33
  article-title: Clarithromycin prevents smoke-induced emphysema in mice
– volume: 71
  start-page: 297
  issue: 2
  year: 2007
  end-page: 305
  ident: 35
  article-title: Effects of macrolides on antigen presentation and cytokine production by dendritic cells and T lymphocytes
– volume: 6
  start-page: 338
  issue: 4
  year: 2005
  end-page: 344
  ident: 9
  article-title: Mechanisms of suppression by suppressor T cells
– volume: 12
  start-page: 178
  issue: 2
  year: 2006
  end-page: 180
  ident: 11
  article-title: Natural regulatory T cells control the development of atherosclerosis in mice
– volume: 67
  start-page: 965
  issue: 7
  year: 2007
  end-page: 974
  ident: 25
  article-title: Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
– volume: 16
  start-page: 523
  issue: 3-4
  year: 1985
  end-page: 534
  ident: 29
  article-title: Passive and active exposure to cigarette smoke in a smoking experiment
– volume: 125
  start-page: 70S
  issue: 2
  year: 2004
  end-page: 78S
  ident: 32
  article-title: Immunomodulatory activity and effectiveness of macrolides in chronic airway disease
– volume: 290
  start-page: L75
  issue: 1
  year: 2006
  end-page: L85
  ident: 20
  article-title: Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells
– volume: 95
  start-page: 765
  issue: 5
  year: 1967
  end-page: 773
  ident: 30
  article-title: The internal surface area of nonemphysematous lungs
– volume: 140
  start-page: 360
  issue: 2
  year: 2005
  end-page: 367
  ident: 14
  article-title: CD4 CD25 T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis
– volume: 117
  start-page: 289
  issue: 3
  year: 2006
  end-page: 300
  ident: 8
  article-title: Imbalance of regulatory T cells in human autoimmune diseases
– volume: 17
  start-page: 638
  issue: 6
  year: 2005
  end-page: 642
  ident: 12
  article-title: How do CD4 CD25 regulatory T cells control autoimmunity?
– volume: 450
  start-page: 566
  issue: 7169
  year: 2007
  end-page: 569
  ident: 10
  article-title: The inhibitory cytokine IL-35 contributes to regulatory T-cell function
– volume: 175
  start-page: 8069
  issue: 12
  year: 2005
  end-page: 8076
  ident: 37
  article-title: Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells
– volume: 58
  start-page: 832
  issue: 10
  year: 2003
  end-page: 834
  ident: 3
  article-title: Hypothesis: does COPD have an autoimmune component?
– volume: 163
  start-page: 1256
  issue: 5
  year: 2001
  end-page: 1276
  ident: 1
  article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary
– volume: 165
  start-page: 1113
  issue: 8
  year: 2002
  end-page: 1118
  ident: 21
  article-title: Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells
– volume: 62
  start-page: 938
  issue: 11
  year: 2007
  end-page: 943
  ident: 17
  article-title: Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial
– volume: 354
  start-page: 1116
  issue: 11
  year: 2006
  end-page: 1176
  ident: 13
  article-title: Regulation of immune responses by T cells
– volume: 1, article e8
  year: 2004
  ident: 5
  article-title: An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema
– volume: 13
  start-page: 567
  issue: 5
  year: 2007
  end-page: 569
  ident: 15
  article-title: Antielastin autoimmunity in tobacco smoking-induced emphysema
– volume: 1
  start-page: 119
  issue: 2
  year: 2002
  end-page: 131
  ident: 23
  article-title: Diffuse panbronchiolitis: role of macrolides in therapy
– volume: 178
  start-page: 1139
  issue: 11
  year: 2008
  end-page: 1147
  ident: 31
  article-title: Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations
– volume: 160
  start-page: S21
  issue: 5
  year: 1999
  end-page: S25
  ident: 6
  article-title: Chronic obstructive pulmonary disease: inflammation of small airways and lung parenchyma
– ident: 17
  doi: 10.1136/thx.2006.071068
– ident: 34
  doi: 10.1164/rccm.200806-905OC
– ident: 14
  doi: 10.1111/j.1365-2249.2005.02754.x
– volume: 95
  start-page: 765
  issue: 5
  year: 1967
  ident: 30
  publication-title: American Review of Respiratory Disease
– volume: 125
  start-page: 70S
  issue: 2
  year: 2004
  ident: 33
  publication-title: Chest
  doi: 10.1378/chest.125.2_suppl.70S
– volume: 18
  start-page: 423
  year: 2000
  ident: 7
  publication-title: Annual Review of Immunology
  doi: 10.1146/annurev.immunol.18.1.423
– ident: 15
  doi: 10.1038/nm1583
– ident: 25
  doi: 10.2165/00003495-200767070-00002
– volume: 1
  start-page: 119
  issue: 2
  year: 2002
  ident: 23
  publication-title: American Journal of Respiratory Medicine
  doi: 10.1007/BF03256601
– ident: 27
  doi: 10.1183/09031936.00000209
– volume: 20
  start-page: 604
  issue: 5
  year: 2008
  ident: 18
  publication-title: Journal of Chemotherapy
  doi: 10.1179/joc.2008.20.5.604
– volume: 165
  start-page: 1113
  issue: 8
  year: 2002
  ident: 21
  publication-title: American Journal of Respiratory and Critical Care Medicine
  doi: 10.1164/ajrccm.165.8.2103094
– ident: 2
  doi: 10.1164/rccm.200703-456SO
– volume: 26
  start-page: 750
  issue: 12
  year: 2003
  ident: 28
  publication-title: Zhonghua Jie He He Hu Xi Za Zhi
– ident: 13
  doi: 10.1056/NEJMra055446
– ident: 5
  doi: 10.1371/journal.pmed.0010008
– ident: 8
  doi: 10.1111/j.1365-2567.2005.02317.x
– volume: 160
  start-page: S21
  issue: 5
  year: 1999
  ident: 6
  publication-title: American Journal of Respiratory and Critical Care Medicine
– ident: 3
  doi: 10.1136/thorax.58.10.832
– ident: 26
  doi: 10.1164/rccm.200707-1134OC
– ident: 9
  doi: 10.1038/ni1180
– ident: 32
  doi: 10.1164/rccm.200801-145OC
– ident: 10
  doi: 10.1038/nature06306
– ident: 11
  doi: 10.1038/nm1343
– volume: 58
  start-page: 145
  issue: 3-4
  year: 1991
  ident: 22
  publication-title: Respiration
  doi: 10.1159/000195915
– volume: 16
  start-page: 523
  issue: 3-4
  year: 1985
  ident: 29
  publication-title: Journal of Toxicology and Environmental Health
  doi: 10.1080/15287398509530760
– ident: 35
  doi: 10.1038/cmi.2009.11
– ident: 36
  doi: 10.1016/j.ijporl.2006.10.016
– volume: 163
  start-page: 1256
  issue: 5
  year: 2001
  ident: 1
  publication-title: American Journal of Respiratory and Critical Care Medicine
  doi: 10.1164/ajrccm.163.5.2101039
– ident: 19
  doi: 10.1002/jcb.22430
– ident: 20
  doi: 10.1152/ajplung.00093.2005
– ident: 16
  doi: 10.1136/thx.2006.072348
– ident: 37
  doi: 10.1016/j.jdermsci.2009.01.007
– ident: 24
  doi: 10.1111/j.1440-1843.2006.00845.x
– ident: 4
  doi: 10.1164/rccm.2107139
– ident: 12
  doi: 10.1016/j.coi.2005.09.002
– volume: 175
  start-page: 8069
  issue: 12
  year: 2005
  ident: 38
  publication-title: The Journal of Immunology
  doi: 10.4049/jimmunol.175.12.8069
– reference: 16462800 - Nat Med. 2006 Feb;12(2):178-80
– reference: 14514931 - Thorax. 2003 Oct;58(10):832-4
– reference: 15807863 - Clin Exp Immunol. 2005 May;140(2):360-7
– reference: 17947611 - Am J Respir Crit Care Med. 2008 Jan 15;177(2):148-55
– reference: 10837065 - Annu Rev Immunol. 2000;18:423-49
– reference: 10556164 - Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S21-5
– reference: 16635082 - Respirology. 2006 May;11(3):249-61
– reference: 17137638 - Int J Pediatr Otorhinolaryngol. 2007 Feb;71(2):297-305
– reference: 16476048 - Immunology. 2006 Mar;117(3):289-300
– reference: 14872003 - Chest. 2004 Feb;125(2 Suppl):70S-78S
– reference: 19060231 - Am J Respir Crit Care Med. 2009 Feb 15;179(4):271-8
– reference: 19407062 - Eur Respir J. 2009 May;33(5):1239
– reference: 17311843 - Thorax. 2007 May;62(5):411-5
– reference: 16209918 - Curr Opin Immunol. 2005 Dec;17(6):638-42
– reference: 19028624 - J Chemother. 2008 Oct;20(5):604-8
– reference: 19251402 - J Dermatol Sci. 2009 Jun;54(3):185-91
– reference: 4087316 - J Toxicol Environ Health. 1985;16(3-4):523-34
– reference: 18723437 - Am J Respir Crit Care Med. 2008 Dec 1;178(11):1139-47
– reference: 19403056 - Cell Mol Immunol. 2009 Apr;6(2):81-6
– reference: 1745845 - Respiration. 1991;58(3-4):145-9
– reference: 16540617 - N Engl J Med. 2006 Mar 16;354(11):1166-76
– reference: 18033300 - Nature. 2007 Nov 22;450(7169):566-9
– reference: 6023510 - Am Rev Respir Dis. 1967 May;95(5):765-73
– reference: 15785759 - Nat Immunol. 2005 Apr;6(4):338-44
– reference: 11316667 - Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76
– reference: 16339544 - J Immunol. 2005 Dec 15;175(12):8069-76
– reference: 17488142 - Drugs. 2007;67(7):965-74
– reference: 14720066 - Am J Respir Med. 2002;1(2):119-31
– reference: 17507545 - Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
– reference: 14720429 - Zhonghua Jie He He Hu Xi Za Zhi. 2003 Dec;26(12):750-5
– reference: 15526056 - PLoS Med. 2004 Oct;1(1):e8
– reference: 17557771 - Thorax. 2007 Nov;62(11):938-43
– reference: 12016104 - Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9
– reference: 17450149 - Nat Med. 2007 May;13(5):567-9
– reference: 19950196 - J Cell Biochem. 2010 Feb 15;109(3):532-41
– reference: 11956054 - Am J Respir Crit Care Med. 2002 Apr 15;165(8):1113-8
– reference: 16085674 - Am J Physiol Lung Cell Mol Physiol. 2006 Jan;290(1):L75-85
SSID ssj0005448
Score 2.1288097
Snippet Heavy smoking can induce airway inflammation and emphysema. Macrolides can modulate inflammation and effector T-cell response in the lungs. However, there is...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
hindawi
emarefa
airiti
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 725
SubjectTerms Animals
CD4-Positive T-Lymphocytes - metabolism
Enzyme-Linked Immunosorbent Assay
Erythromycin - therapeutic use
Forkhead Transcription Factors - metabolism
Interleukin-8 - metabolism
Pneumonia - chemically induced
Pneumonia - drug therapy
Pneumonia - immunology
Pneumonia - metabolism
Rats
Reverse Transcriptase Polymerase Chain Reaction
Smoking - adverse effects
Tumor Necrosis Factor-alpha - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBejsLGXsa9u3hca69OKaKwPy37cspRurGN0LfRNSLJEwlK7JCkl_33vLCfUo2wvewpyLsKn-0l3F0m_I2QvF0XlrLMM3MGIyVrXrHQiMqxtXJcir7XHu8PHP4qjM_ntXJ3fKvWFZ8ISPXAauAOpbXQqQJRipbQ22tzFMugCoDoSoa5x9QWft0mmNoc7ZFc3C-Jzziqh8v5mHjhPyPZzfiCRsYCD17Ez5A4aOKWOu7-7oGuhDQ7r_hTT4-vZXUHon2cpbzmnw8fkUR9V0k9JmyfkXmiekgfH_b75M9JMFmssiHCxhjadNFO09ZKOv8h9cD-XYp-epJr07WJNT9k4zOfwpDs9C2LwE0tP7Ipi4bQ5bSP9ddH-DgzLfvhQ0--wYNCvTQRwpYuQz8nZ4eR0fMT6SgvMKlGsmI4WkuqofBHKIKvCe899nZdWWytjIZB1LsKIY3ZTOmdzASYpi2IUpBe-imKX7DRtE14SOuIeMhRVlkIGqQKkU1UNYUzFo7PcjXhGJmnMTT9ZluYnR5o7hVvgwqB5co4fuBYhQ5QcNjRXRguRkY8bkxnf05ljVY256dIapbqeTDJ0Rva2wpeJxeNusc9o-60IUm93DwCQpgek-RcgM7LbI2fbD6S0FWr-oQfS39_h_QZkBmY6bt_YJrRXSxDmyDcIAWJGXiTQbTviMHg51zIjegDHgSrDb5rZtGMTFwKrNKpX_0P31-QhqpL-onpDdlaLq_AWgraVe9fNzxuy8TUx
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdgEogXND7GwgAZsScmi8QfcfIIpVNBDKGxSX2zHMdWK7pkajuh_vfcJV4hY0I8RU4ulp07--5i-_cj5DATeVnZyjJwBymTta5ZUYnAkNu4LkRWa4dnh0--5pNz-XmqpnGD7OrvJXzwdpCeZ_ydRIgBmGrvgn1hTj6Z_t7IITuOLIjFOSuFyuIpvBuvgoexc8QJGjigDqe_O4xroQzO6d4MU-Gf89sCzpv7Jv9wRMe75GGMIOn7XuWPyB3fPCb3T-Ia-RPSjJcbJD-42ECZjpsZ6nVFRx_lEbiaS3FET3v--Xa5oWds5BcLuNPtlAUxeMXSU7umSJK2oG2g3y_aH54hxYfzNf0CkwP91AQwpP7Q41Nyfjw-G01YZFVgVol8zXSwkEAH5XJfeFnmzjnu6qyw2loZcoEIcwEmAsxkiqqymaiUL_I89dIJVwaxR3aatvH7hKbcQTaiikJIL5WH1KmsIWQpeagsr1KekHH_zU0cGCvzjSOkncLlbmFQPRnHC847iAYlhwXNldFCJOTttcqMi9DlyKCxMF0Ko1RXk-kVnZDDrfBlj9hxu9gH1P1WBGG2uxtgeiaOWiO1DdB7CJGtlNYGm1Wh8DpPsfm-rhOyFy1nWw-kryX2_E00pH-34fW1kRkY1bhUYxvfXq1AmCO2IASDCXnWG922Ig4fL-NaJkQPzHHQleGTZj7rkMOFQEZG9fy_WndAHmCp_9_0guysl1f-JURg6-pVNwB_AWUmILY
  priority: 102
  providerName: Hindawi Publishing
Title Erythromycin Enhances CD4^+Foxp3^+ Regulatory T-Cell Responses in a Rat Model of Smoke-Induced Lung Inflammation
URI https://www.airitilibrary.com/Article/Detail/P20160527003-201212-201703010014-201703010014-725-733
https://search.emarefa.net/detail/BIM-998902
https://dx.doi.org/10.1155/2012/410232
https://www.ncbi.nlm.nih.gov/pubmed/22701274
https://www.proquest.com/docview/1020828355
https://pubmed.ncbi.nlm.nih.gov/PMC3371355
https://doaj.org/article/47afb5e774a44aafa1bf8e7607003edd
Volume 2012
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELemIRAviK9BBlRG7IkpkPgzeUAIRqcCKkJolfoWOYlNK7pkSztB_3vunLSQqUK8tHJ6cW3f2XfnxL8fIUcxV2luchOCO4hCUeoyTHLuQuQ2LhMel7rAs8PjL2o0EZ-mcrpHNmSc3QAud6Z2yCc1aRavfl2u38KEf-MnvJSQv8fstUAMAliLb4BL0khlMBZ_YMOl8DRasCqoME5U3B3Uu3YzOCEzRyihno_yUP7-vK6BMvivmzPMln_Od8Wk11-t_MtXnd4ld7ogk75rreIe2bPVfXJr3D1Gf0CqYbNGfoTzNZSprWao-iU9-SCOwRtd8GPatBT1dbOmZyFu7sMV_zItiMEthoLhUM-iQ2tHl-f1DxtCe8FOSrqA9QOEHNhaey7yIZmcDs9ORmFHvBAaydUq1M5Aju1koWxiRaqKomBFGSdGGyOc4ghC52CtwGQnyXMT81zaRKnIioIXqeMHZL-qK_uY0IgVkLDIJOHCCmkhu0pLiGpS5nLD8ogFZNiOebZRffaVIeqdxCfiPEP1xAy_cGlCwCjRL2gmM815QF5uVJYVHbo5kmwsMp_lSOlrylpFB-RoK3zRgnrsFnuPut-KIBK3v1A337NuYmdCGwe9hyjaCGGMM3HuEqtVhM23ZRmQg85ytvVAhptiz190hvTvNjzfGFkGEx8VbipbXy1BmCH8IMSLAXnUGt22IgaDFzMtAqJ75tjrSv-Xaj7z4OKcI2mjPPyP_31CbmNL2w2pp2R_1VzZZxCirfIBJCcfPw_8BsfAT0X4_Daa_gZMXTNA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Erythromycin+enhances+CD4%2BFoxp3%2B+regulatory+T-cell+responses+in+a+rat+model+of+smoke-induced+lung+inflammation&rft.jtitle=Mediators+of+inflammation&rft.au=Bai%2C+Jing&rft.au=Qiu%2C+Shi-Lin&rft.au=Zhong%2C+Xiao-Ning&rft.au=Huang%2C+Qiu-Ping&rft.date=2012-01-01&rft.issn=1466-1861&rft.eissn=1466-1861&rft.volume=2012&rft.spage=410232&rft_id=info:doi/10.1155%2F2012%2F410232&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon